Logo 1 Logo 2

Clinical Trial Details

Trial ID: L0486
Source ID: NCT00091975
Associated Drug: Zemplar Capsule
Title: Zemplar® Capsule in Reducing Serum Intact Parathyroid Hormone Levels in Chronic Kidney Disease Stage 5 Subjects on Hemodialysis or Peritoneal Dialysis
Acronym:
Status: COMPLETED
Study Results: NO
Results:
Conditions: Kidney Disease
Interventions: DRUG: Zemplar Capsule
Outcome Measures: Primary: The efficacy endpoint is achievement of two consecutive > or = 30% decreases from baseline in iPTH levels |
Sponsor/Collaborators: Sponsor: Abbott
Gender: ALL
Age: ADULT, OLDER_ADULT
Phases: PHASE3
Enrollment: 78
Study Type: INTERVENTIONAL
Study Designs: Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: DOUBLE|Primary Purpose: TREATMENT
Start Date: 2004-08
Completion Date:
Results First Posted:
Last Update Posted: 2011-01-19
Locations: California Institute of Renal Research, San Diego, California, 92120, United States|Georgetown University Medical Center, Washington, District of Columbia, 60057, United States|Associates in Nephrology, Fort Meyers, Florida, 33908, United States|University of Florida, Gainesville, Florida, 32610, United States|Outcomes Research International, Inc., Hudson, Florida, 34667, United States|Evanston Northwestern Healthcare, Evanston, Illinois, 60201, United States|Indiana University School of Medicine, Indianapolis, Indiana, 46202, United States|Tulane University School of Medicine, New Orleans, Louisiana, 70112-2699, United States|Washington University Medical Center, St. Louis, Missouri, 63108, United States|St. Louis University, St. Louis, Missouri, 63110, United States|Nea Research, Las Vegas, Nevada, 89102, United States|University of Cincinnati College of Medicine, Cincinnati, Ohio, 45267-0585, United States|Northwestern Renal Clinic, INC., Portland, Oregon, 97210, United States|Nephrology Associates, P.C., Nashville, Tennessee, 37205, United States|Kidney Associates, PLLC, Houston, Texas, 77030, United States|University of Texas Health Center at San Antonio, San Antonio, Texas, 78229, United States
URL: https://clinicaltrials.gov/show/NCT00091975

Drug ID Drug Name Type DrugBank ID Targets Category Latest Progress